Autistic Disorder
|
0.300 |
Biomarker
|
disease |
CTD_human |
Children with autism/ASD had significantly higher levels of many growth-related hormones: IGF-1, IGF-2, IGFBP-3 and GHBP.
|
17547689 |
2007 |
Myocardial Ischemia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Cardioplegia prevents ischemia-induced transcriptional alterations of cytoprotective genes in rat hearts: a DNA microarray study.
|
16214533 |
2005 |
Prostatic Neoplasms
|
0.310 |
Biomarker
|
group |
CTD_human |
Haplotype-based analysis of common variation in the growth hormone receptor gene and prostate cancer risk.
|
17220348 |
2007 |
Malignant neoplasm of prostate
|
0.340 |
Biomarker
|
disease |
CTD_human |
These results suggest that whereas genetic variation in the GHR gene does not seem to play a major role in prostate cancer etiology, one haplotype in the 3' region may be potentially relevant to cases with later onset of prostate cancer.
|
17220348 |
2007 |
Liver carcinoma
|
0.350 |
Biomarker
|
disease |
CTD_human |
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
|
28284560 |
2017 |
Liver Cirrhosis, Experimental
|
0.500 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Liver Cirrhosis, Experimental
|
0.500 |
Biomarker
|
disease |
CTD_human |
Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis.
|
17072980 |
2006 |
INCREASED RESPONSIVENESS TO GROWTH HORMONE
|
0.500 |
GermlineCausalMutation
|
phenotype |
ORPHANET |
|
|
|
INCREASED RESPONSIVENESS TO GROWTH HORMONE
|
0.500 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
|
|
|
INCREASED RESPONSIVENESS TO GROWTH HORMONE
|
0.500 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
|
|
|
INCREASED RESPONSIVENESS TO GROWTH HORMONE
|
0.500 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
|
|
|
INCREASED RESPONSIVENESS TO GROWTH HORMONE
|
0.500 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
|
|
|
Hyperlipoproteinemia Type IIa
|
0.510 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hyperlipoproteinemia Type IIa
|
0.510 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Hyperlipoproteinemia Type IIa
|
0.510 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Hyperlipoproteinemia Type IIa
|
0.510 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Hyperlipoproteinemia Type IIa
|
0.510 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Short Stature, Idiopathic, Autosomal
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group.
|
7565946 |
1995 |
Short Stature, Idiopathic, Autosomal
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Short Stature, Idiopathic, Autosomal
|
0.720 |
GermlineCausalMutation
|
disease |
ORPHANET |
|
|
|
Short Stature, Idiopathic, Autosomal
|
0.720 |
Biomarker
|
disease |
CTD_human |
|
|
|
Short Stature, Idiopathic, Autosomal
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Short Stature, Idiopathic, Autosomal
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Short Stature, Idiopathic, Autosomal
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Laron Syndrome
|
1.000 |
GermlineCausalMutation
|
disease |
ORPHANET |
We studied 22 patients with LS from Ecuador, Israel (of Moroccan origin), Brazil, Chile, and the United States (of Mexican origin) who were homozygous for the E180splice mutation and compared them to control individuals for markers surrounding the GHR, intragenic polymorphisms, and Y-chromosome STR.
|
24664892 |
2014 |